Can patient-derived iPSCs be applied to phenotypic cell-based high throughput screening assessment to distinguish between different types of long-QT syndrome?

Back

ESC Premium Access

Can patient-derived iPSCs be applied to phenotypic cell-based high throughput screening assessment to distinguish between different types of long-QT syndrome?

Session: Cardiac disease modelling

Topic: Ion Channels, Electrophysiology

Speaker: Mr D. Yoshinaga (Boston, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mr Daisuke Yoshinaga

Boston Children's Hospital, Boston (United States of America)

0 follower

5 more presentations in this session

Electrically silent and stimulable iPSC-derived cardiomyocytes using RNA-guided epigenome editing

Speaker: Professor J. Hulot (Paris, FR)

Access

Abstract

Generation of disease specific iPSC-derived cardiomyocyte and investigation of their characteristics: study with clinically divergent female monozygotic twins with Danon disease.

Speaker: Doctor S. Yoshida (Kanazawa, JP)

Exploring hypertrophic cardiomyopathy in iPSC-derived cardiomyocytes from patients with a novel autosomal recessive form of Noonan syndrome

Speaker: Doctor L. Cyganek (Gottingen, DE)

Access

Abstract

A novel platform to maintain adult cardiac tissue in vitro: myocardial slices and electromechanical stimulation with physiological preload

Speaker: Mr S. Watson (London, GB)

Functional analysis of induced pluripotent stem cell-derived cardiomyocytes from patients with hypoplastic left heart syndrome in engineered heart tissues

Speaker: Doctor Z. Zhang (Munich, DE)

Access the full session

Cardiac disease modelling

Speakers: Mr D. Yoshinaga, Professor J. Hulot, Doctor S. Yoshida, Doctor L. Cyganek, Mr S. Watson...

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources